Papers
10
Total Citations
1,136
H-Index
9
About
Atreya Dash is a leading urologic surgeon and researcher whose work has fundamentally shaped the modern surgical management of bladder cancer. His primary research focus is the rigorous, evidence-based comparison of robot-assisted versus open radical cystectomy, a complex procedure for muscle-invasive bladder cancer. Dash is best known as a key investigator in the landmark **RAZOR trial**, the first multi-institutional, randomized phase 3 study to demonstrate that robot-assisted radical cystectomy is non-inferior to the open approach for 2-year progression-free survival. This seminal 2018 publication has garnered over **760 citations**, fundamentally altering surgical practice. His subsequent analyses from the RAZOR trial have provided crucial insights into long-term survival outcomes, health-related quality of life, and complication rates, with several follow-up papers accumulating hundreds of additional citations. Beyond oncology, Dash has advanced the field of reconstructive urology, pioneering techniques for robotic bladder neck reconstruction to treat challenging post-surgical strictures. Through his leadership in the Trauma and Urologic Reconstructive Network of Surgeons (TURNS), he has established new standards for minimally invasive management of these complex conditions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7Robotic radical anterior pelvic exenteration: The UCI experience19 citations · 2010
- 8Antecedentes, desarrollo y situación actual de la robótica en cirugía11 citations · 2007
- 9
- 10